You are here

  • Home
  • Archive
  • Volume 5, Issue 3
  • Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial

Citation Tools

Article menu
XML
Infectious diseases
Protocol
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Shaw E, Miró JM, Puig-Asensio M on behalf of the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III, Madrid, Spain, and GEIH (Hospital Infection Study Group), et al
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial
BMJ Open 2015;5:e006723. doi: 10.1136/bmjopen-2014-006723